Envision Healthcare Co. (EVHC) Shares Sold by Hahn Capital Management LLC
Hahn Capital Management LLC lessened its position in Envision Healthcare Co. (NYSE:EVHC) by 38.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 303,676 shares of the company’s stock after selling 189,552 shares during the quarter. Hahn Capital Management LLC owned 0.25% of Envision Healthcare worth $13,650,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of EVHC. Janus Henderson Group PLC boosted its position in Envision Healthcare by 36,086.8% during the second quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock valued at $247,239,000 after buying an additional 3,934,185 shares during the period. OZ Management LP purchased a new stake in shares of Envision Healthcare during the third quarter worth about $131,987,000. Maverick Capital Ltd. boosted its holdings in shares of Envision Healthcare by 66.2% during the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after purchasing an additional 2,028,026 shares during the period. Lord Abbett & CO. LLC boosted its holdings in shares of Envision Healthcare by 259.6% during the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock worth $82,808,000 after purchasing an additional 953,928 shares during the period. Finally, Westfield Capital Management Co. LP purchased a new stake in shares of Envision Healthcare during the second quarter worth about $45,892,000.
A number of analysts have recently weighed in on the stock. Citigroup lowered shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 target price for the company. in a report on Thursday, November 2nd. BidaskClub lowered shares of Envision Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, August 17th. Bank of America decreased their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, October 9th. Piper Jaffray Companies began coverage on shares of Envision Healthcare in a research note on Wednesday. They issued a “neutral” rating and a $35.00 price target for the company. Finally, Canaccord Genuity reissued a “buy” rating and issued a $32.00 price target (down from $68.00) on shares of Envision Healthcare in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating, seven have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $46.06.
Shares of Envision Healthcare Co. (NYSE EVHC) traded down $0.03 during midday trading on Thursday, hitting $33.37. 4,039,400 shares of the company’s stock were exchanged, compared to its average volume of 2,267,143. Envision Healthcare Co. has a fifty-two week low of $23.77 and a fifty-two week high of $73.00. The company has a market capitalization of $4,037.10, a P/E ratio of 10.31, a price-to-earnings-growth ratio of 0.87 and a beta of 0.57. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89.
Envision Healthcare (NYSE:EVHC) last announced its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. During the same period in the prior year, the business posted $1.13 EPS. Envision Healthcare’s revenue for the quarter was up 142.0% on a year-over-year basis. research analysts forecast that Envision Healthcare Co. will post 2.56 earnings per share for the current year.
Envision Healthcare announced that its Board of Directors has authorized a stock buyback plan on Monday, September 18th that permits the company to buyback $250.00 million in shares. This buyback authorization permits the company to reacquire up to 4.5% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.